Kewaunee Q3 FY2024 EPS $0.85 vs $0.25 YoY; net income triples despite 23% sales drop

KEWAUNEE SCIENTIFIC CORP /DE/

2024-Q3 EPS reported $2.64 revenue$147,053,000

Sales $46.8M, down 23% YoY from $60.8M; net income $2.5M vs $0.7M.
Diluted EPS $0.85 (prior year $0.25); EBITDA $4.4M vs $2.7M.
Domestic segment net income rose to $2.6M from $0.4M on improved productivity.
International sales fell 39% to $15.0M due to two large non-recurring projects.
Cash on hand $27.1M, up from $13.8M at April 2023; debt-to-equity improved to 0.87.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

KEWAUNEE SCIENTIFIC CORP /DE/ reported third quarter ended January 31, 2024 results: revenue $46,778,000, net income $2,521,000, EPS $0.85.

Period: third quarter ended January 31, 2024
Revenue: $46,778,000
Net income: $2,521,000
EPS: $0.85
Result: reported results

Exact text from the filing

Sales during the third quarter of fiscal year 2024 were $46,778,000, a decrease of 23.1% compared to sales of $60,821,000 from the prior year's third quarter. Pre-tax earnings for the quarter were $3,515,000 compared to $2,060,000 for the prior year quarter, an increase of 70.6%. Net earnings were $2,521,000 compared to net earnings of $723,000 for the prior year quarter. EBITDA 1 for the quarter was $4,414,000 compared to $2,683,000 for the prior year quarter. Diluted earnings per share was $0.85 compared to diluted earnings per share of $0.25 in the prior year quarter.

View on SEC.gov

310 earnings releases filed in the last 30 days. Browse all earnings releases →

KEWAUNEE SCIENTIFIC CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000055529-24-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.